KCSG HN15-16두경부식도암
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC): In-Depth Analysis of Nintendanib Arm from the KCSG HN15-16 TRIUMPH Trial
- 저널 Cancer Res Treat . 2023 Jul 20. doi: 10.4143/crt.2023.433.
- 제1저자 김규현, 임선민
- 교신저자 김진수